Print 2
Obstructive Airway Pathologies: Asthma & Paradoxical Vocal Fold Movement
Asthma Pathophysiology & Presentation:
Chronic lower airway disease characterized by bronchial inflammation, bronchoconstriction, and excessive mucus viscosity.
Impairs expiration, reducing respiratory driving pressure for speech and causing wheezing, coughing, and chest tightness.
Secondary clinical impacts include dysphagia from altered tongue movements and delayed swallow reflex initiation.
Medical management includes inhaled corticosteroids, bronchodilators, nebulizers, and leukotriene modifiers.
Paradoxical Vocal Fold Movement (PVFM):
Episodic upper airway obstruction characterized by abnormal adduction of true vocal folds during inspiration.
Triggers dyspnea, inhalatory stridor, panic, and an acute inability to phonate or safely coordinate swallowing.
Etiologies categorized as organic, environmental, or psychosocial.
Speech-Language Pathology Interventions:
Asthma: Vocal hygiene education, rinsing after inhaler use, cough-suppression techniques, and swallow-respiration pacing.
PVFM: Direct techniques including relaxed-throat breathing, pursed-lip breathing, and diaphragmatic breathing; indirect methods include irritant avoidance, desensitization (such as Heliox mask), laryngeal massage, and supportive counseling.
Chronic Cardiopulmonary Conditions: COPD & Congestive Heart Failure
Chronic Obstructive Pulmonary Disease (COPD):
Progressive, irreversible condition encompassing chronic bronchitis and emphysema leading to airway obstruction and alveolar destruction.
Produces breathy voice quality, reduced vocal loudness, short phrase duration, and high risk of aspiration due to discoordination between breathing and swallowing.
Interventions include smoking cessation, bronchodilators, anti-inflammatory inhalers, oxygen therapy, and pulmonary rehabilitation.
Congestive Heart Failure (CHF):
Progressive cardiac failure where weakened or stiffened ventricles fail to pump adequate systemic blood flow, leading to organ congestion and fluid backup.
Manifests with exertional dyspnea, conversational breathlessness, vocal fatigue, and secondary dysphagia from general weakness or intubation.
Medical management consists of sodium restriction (), diuretics, ACE inhibitors, ARBs, ARNIs, and beta-blockers.
Clinical Swallowing & Speech Management:
Assessments include Clinical Swallowing Evaluations, Videofluoroscopic Swallowing Studies (VFSS), and Fiberoptic Endoscopic Evaluation of Swallowing (FEES).
Therapeutic interventions center on compensatory strategy training ( reporting rate among treating SLPs), breathing-swallowing coordination, diet/liquid modification, and phrase-length management.
Progressive Motor Neuron & Neurodegenerative Disorders: ALS, FA, & Parkinson's Disease
Amyotrophic Lateral Sclerosis (ALS):
Progressive degeneration of upper and lower motor neurons; approximately of cases possess a genetic basis.
Symptoms begin with muscle twitching, cramping, and distal extremity weakness, progressing to mixed dysarthria, profound dysphagia, and respiratory failure.
Medical therapies include Riluzole, Edaravone, and Qalsody (tofersen) for SOD1 mutations; ventilatory support includes noninvasive ventilation and tracheostomy.
SLP focus: Early alternative and augmentative communication (AAC) implementation, energy preservation, and swallow safety.
Friedreich's Ataxia (FA):
Inherited autosomal recessive disease caused by trinucleotide GAA repeat expansions ( repeats) in the FXN gene on chromosome 9, affecting individuals globally.
Onset occurs between ages 5 and 15, damaging the cerebellum, spinal cord, and peripheral nerves; individuals are frequently wheelchair-bound after 10 to 20 years.
Characterized by sensory and motor ataxia, scoliosis, dysarthria, and dysphagia. Medication includes Skyclarys; SLP interventions use Expiratory Muscle Strength Training (EMST) and Lee Silverman Voice Treatment (LSVT).
Parkinson's Disease (PD):
Degeneration of dopaminergic neurons within the substantia nigra, depleting dopamine in the basal ganglia.
Cardinal motor signs: Bradykinesia, rigidity, resting tremor, and masked facial expressions (hypomimia).
Speech and respiratory deficits: Hypokinetic dysarthria in approximately of individuals, dysphagia in , reduced vital capacity (), chest wall excursion restriction, and irregular respiratory cycles.
Interventions: Carbidopa-Levodopa pharmacotherapy, Deep Brain Stimulation (DBS), LSVT LOUD, EMST/IMST, air-stacking maneuvers, and sensorimotor airway protection training.
Demyelinating & Spinal Disorders: Multiple Sclerosis & Spinal Cord Injury
Multiple Sclerosis (MS):
Autoimmune demyelination of the central nervous system marked by sclerotic plaques across oligodendroglia; subtypes include benign, relapsing-remitting, remitting-progressive, and progressing.
Speech/Voice/Cognitive signs: Mixed spastic-ataxic dysarthria, scanning speech, vocal cord paresis causing breathy/harsh dysphonia, cognitive-linguistic processing delays, word-finding deficits (), and dysphagia.
SLP treatments: LSVT LOUD protocols for hypophonia, compensatory swallowing strategies, assisted cough maneuvers, and diadochokinetic (DDK) diagnostic rate tracking.
Spinal Cord Injury (SCI):
Neurological disruption classified as complete (loss of all motor/sensory function below injury) or incomplete.
High cervical lesions () impact the phrenic motor nucleus ( innervating the diaphragm), producing partial or total diaphragmatic paralysis.
Thoracic lesions compromise intercostal and abdominal muscle activation, diminishing peak cough flow, vital capacity, and voice projection.
Dysphagia occurs in approximately of cervical SCI patients. Management involves mechanical ventilation, diaphragm pacing, noninvasive ventilatory assistance, and speaking valve accommodation.

Musculoskeletal & Structural Spinal Disorders
Structural Deformities:
Scoliosis: Lateral spinal curvature disrupting vertical alignment, compressing thoracic cavities and impeding lung inflation.
Lordosis: Exaggerated anterior lumbar curvature ("swayback") limiting ribcage excursion; cervical lordosis directly impairs anterior-superior laryngeal elevation during deglutition.
Kyphosis: Exaggerated posterior thoracic curvature (e.g., Dowager's hump from osteoporosis) causing mechanical inefficiency of suprahyoid muscles during swallowing.
Myotonic Muscular Dystrophy: Membrane breakdown and intracellular calcium overload driving progressive muscle atrophy, leading to flaccid dysarthria and ventilatory insufficiency.

Diagnostic Instruments & Therapies:
Assessments: Consensus Auditory-Perceptual Evaluation of Voice (CAPE-V), Voice Handicap Index (VHI), Goldman-Fristoe Test of Articulation (GFTA-3), Khan-Lewis Phonological Analysis (KLPA-3), FEES, and Modified Barium Swallow Studies (MBSS).
Interventions: Laryngeal Manual Therapy (LMT) to reduce hyperfunctional muscle tension, posture/head positioning modifications, pacing, and clear speech articulation drills.
Airway Management: Tracheostomy & Mechanical Ventilation
Physiological Impact:
Placement of a tracheostomy tube bypasses the upper airway, eliminating natural warming, humidification, and filtration of air.
Diversion of expired air through the tracheal stoma disrupts airflow across true vocal cords, causing aphonia.
Cuff inflation anchors the larynx against the cervical spine, reducing laryngeal elevation, blunting subglottic pressure generation, and extinguishing sensory feedback.

Clinical Indications & Risks:
Indicated for acute respiratory failure, prolonged mechanical ventilation, traumatic brain injury, bilateral vocal fold paralysis, and terminal neuromuscular conditions.
Potential complications include tracheal stenosis, disuse vocal cord edema, secretion pooling, silent aspiration, and chronic ventilator dependency.
Speech-Language Pathology Care Protocol:
Evaluates tolerance of complete cuff deflation in conjunction with respiratory therapy and medical staff.
Assesses suitability for one-way speaking valves (e.g., Passy-Muir valve) to restore subglottic pressure, enhance olfaction, facilitate cough clearance, and re-establish oral communication.
Establishes low- or high-tech AAC modalities for non-vocal patients and implements swallow screening with oral-hygiene maintenance.